Nasdaq, S&P sink in stock rout fueled by tech weakness, tariff haziness
U.S. stock losses accelerated Thursday afternoon, with the Nasdaq Composite (COMP:IND) undergoing its worst day in nearly ...
One Line From Nvidia's Earnings Call That AMD Investors Should Be Wary Of
Advanced Micro Devices, Inc. stock tumbles 54% from its high as Nvidia's recent earnings signal trouble. Explore more details ...
Stock market today: Dow, S&P 500, Nasdaq fall as Trump announces more tariff exemptions from Mexico
US stocks fell on Thursday after President Trump announced temporary exemptions on tariffs against Mexico, though the same ...
Stock market today: Dow, S&P 500, Nasdaq drop amid tariff turmoil, earnings misses
US stocks plummeted early Thursday after downbeat earnings from Marvell (MRVL) and Macy's (M), as investors continued to ...
1 TFSA Stock That’s a Screaming Buy for March
Here's why Canadian investors should consider holding quality growth stocks such as Advanced Micro Devices in a TFSA. The ...
Ocugen, Inc. (NASDAQ:OCGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 5, 2025 Ocugen, Inc. reports earnings inline with expectations. Reported EPS is $-0.05 ...
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...
Stock market today: Dow, S&P 500, Nasdaq set to slide amid tariff turmoil, earnings misses
US stock futures sold off on Thursday after downbeat earnings from Marvell (MRVL) and Macy's (M), as investors continued to ...
Devdiscourse7h
US STOCKS-Futures fall as tariff uncertainty prevails; chipmakers slide
Futures off: Dow 0.84%, S&P 500 1.03%, Nasdaq 1.27% (Updates with analyst comment) ...
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD
CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD - - Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other ...